Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemia

Published:1992-01 Issue:6 Volume:6 Page:493-496
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gruber Astrid¹²,Liliemark Jan²³,Tidefelt Ulf³,Knochenhauer Eva²,Arestrom Irene²,Sundman-Engberg Britt³,Bjorkholm Magnus¹,Paul Christer³,Peterson Curt²

Affiliation:

1. Division of Hematology and Immunology, Department of Medicine, Stockholm, Sweden

2. Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden

3. Division of Clinical Hematology and Oncology, Department of Medicine, Huddinge Hospital, Huddinge, Sweden

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428199209053588

Reference14 articles.

1. Mitozantrone-induced toxicity and DNA strand breaks in leukaemic cells

2. Pharmacokinetics and Metabolism of Mitoxantrone

3. Pharmacology of mitoxantrone in cancer patients

4. Mitoxantrone, Etoposide and Cytarabine in the Treatment of Acute Nonlymphocytic Leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Single Dose of Mitoxantrone and Cytarabine in Acute Non-Lymphocytic Leukemia: A Pharmacokinetic and Clinical Study;Therapeutic Drug Monitoring;1998-12

2. Mitoxantrone;Drugs & Aging;1996-08

3. Correlation between sensitivity in vitro of patient chronic lymphocytic leukemia cells and clinical systemic exposure at the maximum tolerated dose for cell cycle phase-specific (type 2) anticancer drugs;Anti-Cancer Drugs;1996-01

4. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion—a randomised study;European Journal of Cancer;1995-12

5. Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia—Relationship to treatment outcome and bone marrow toxicity;Leukemia Research;1995-10